Baxdrostat and Molecular Imaging of Adrenal Cytoreduction in Primary Aldosteronism
Baxdrostat and Molecular Imaging of Adrenal Cytoreduction in Primary Aldosteronism
Not yet recruiting · NCT07800858 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Baxdrostat and Molecular Imaging of Adrenal Cytoreduction in Primary Aldosteronism | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Not yet recruiting | Not applicable | 2026-09-02 | NCT07800858 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Queen Mary University of London | 102 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Barts NHS Trust | London | United Kingdom | 2 |
| Cambridge NHS Foundation Trust | Cambridge | United Kingdom | 1 |